Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Arimoclomol> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- Arimoclomol abstract "Arimoclomol (INN, originally codenamed BRX-345, which is a citrate salt formulation of BRX-220) is an experimental drug developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS).".
- Arimoclomol atcPrefix "none".
- Arimoclomol casNumber "289893-25-0".
- Arimoclomol fdaUniiCode "EUT3557RT5".
- Arimoclomol iupacName "N-{[(2R)-2-hydroxy-3-piperidin-1-ylpropyl]oxy}pyridine-3-carboximidoyl chloride 1-oxide".
- Arimoclomol pubchem "208924".
- Arimoclomol thumbnail Arimoclomol.svg?width=300.
- Arimoclomol wikiPageID "4802464".
- Arimoclomol wikiPageRevisionID "598539145".
- Arimoclomol atcPrefix "none".
- Arimoclomol c "14".
- Arimoclomol casNumber "289893".
- Arimoclomol chemspiderid "21106260".
- Arimoclomol cl "1".
- Arimoclomol h "20".
- Arimoclomol hasPhotoCollection Arimoclomol.
- Arimoclomol inchi "1".
- Arimoclomol inchikey "SGEIEGAXKLMUIZ-ZPTIMJQQBD".
- Arimoclomol iupacName "N-{[-2-hydroxy-3-piperidin-1-ylpropyl]oxy}pyridine-3-carboximidoyl chloride 1-oxide".
- Arimoclomol legalStatus "Investigational".
- Arimoclomol molecularWeight "313.78".
- Arimoclomol n "3".
- Arimoclomol o "3".
- Arimoclomol pubchem "208924".
- Arimoclomol routesOfAdministration "Oral".
- Arimoclomol smiles "O[C@H]CO\N=Cc2ccc[n+]c2".
- Arimoclomol stdinchi "1".
- Arimoclomol stdinchikey "SGEIEGAXKLMUIZ-ZPTIMJQQSA-N".
- Arimoclomol unii "EUT3557RT5".
- Arimoclomol verifiedrevid "447557873".
- Arimoclomol subject Category:Drugs.
- Arimoclomol type Agent114778436.
- Arimoclomol type CausalAgent100007347.
- Arimoclomol type Drug103247620.
- Arimoclomol type Drugs.
- Arimoclomol type Matter100020827.
- Arimoclomol type PhysicalEntity100001930.
- Arimoclomol type Substance100020090.
- Arimoclomol type Drug.
- Arimoclomol type DrugProduct.
- Arimoclomol type FunctionalSubstance.
- Arimoclomol comment "Arimoclomol (INN, originally codenamed BRX-345, which is a citrate salt formulation of BRX-220) is an experimental drug developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS).".
- Arimoclomol label "Arimoclomol".
- Arimoclomol sameAs m.0cnz9w.
- Arimoclomol sameAs Q4790694.
- Arimoclomol sameAs Q4790694.
- Arimoclomol sameAs Arimoclomol.
- Arimoclomol wasDerivedFrom Arimoclomol?oldid=598539145.
- Arimoclomol depiction Arimoclomol.svg.
- Arimoclomol isPrimaryTopicOf Arimoclomol.
